Yanlin has a background in psychology, specializing in family and cognitive factors' impact on #resilience and #mentalhealth, and is now expanding her expertise to include genetics. 🧬
www.r2d2-mh.eu/team/early-c...
#HorizonEU
Yanlin has a background in psychology, specializing in family and cognitive factors' impact on #resilience and #mentalhealth, and is now expanding her expertise to include genetics. 🧬
www.r2d2-mh.eu/team/early-c...
#HorizonEU
In #R2D2MH, Hanna investigates the neuroanatomy of #resilience and vulnerability with regards to functioning in #autism.
www.r2d2-mh.eu/team/early-c...
#HorizonEU
In #R2D2MH, Hanna investigates the neuroanatomy of #resilience and vulnerability with regards to functioning in #autism.
www.r2d2-mh.eu/team/early-c...
#HorizonEU
In #R2D2MH, Lucas models #resilience as risk-to-outcome mappings to understand what supports resilience in #neurodiversity.
www.r2d2-mh.eu/team/early-c...
@cogneurolucas.bsky.social #HorizonEU
In #R2D2MH, Lucas models #resilience as risk-to-outcome mappings to understand what supports resilience in #neurodiversity.
www.r2d2-mh.eu/team/early-c...
@cogneurolucas.bsky.social #HorizonEU
Kim Tönis, PhD candidate at @UTwente, contributes to the research that leads to ADAPPT, supporting the #MentalHealth of parents of #neurodivergent children📱
More about ADAPPT: www.r2d2-mh.eu/cohorts-and-...
#HorizonEU #Resilience
Kim Tönis, PhD candidate at @UTwente, contributes to the research that leads to ADAPPT, supporting the #MentalHealth of parents of #neurodivergent children📱
More about ADAPPT: www.r2d2-mh.eu/cohorts-and-...
#HorizonEU #Resilience
Thomas Dinneen, postdoctoral research fellow at @sickkidsto.bsky.social in the group of @louisegallagher.bsky.social, translates findings from the pilot study of families with #NRXN1 deletions into precision medicine.
#HorizonEU #Resilience #RareDisease
Thomas Dinneen, postdoctoral research fellow at @sickkidsto.bsky.social in the group of @louisegallagher.bsky.social, translates findings from the pilot study of families with #NRXN1 deletions into precision medicine.
#HorizonEU #Resilience #RareDisease